Table 3.
Changes in HbA1c levels and serum fucoxanthinol (FxOH) levels in the fucoxanthin (Fx) intervention groups (0 or 1 or 2 mg/d) after the 8-week intervention†
(Mean values with their standard errors)
| Fx 0 mg | Fx 1 mg | Fx 2 mg | ||||
|---|---|---|---|---|---|---|
| Mean | se | Mean | se | Mean | se | |
| ΔHbA1c (%) | 0·06 | 0·05 | 0·01 | 0·05 | −0·14* | 0·05 |
| Serum FxOH levels (after 8 weeks) (nm) | 0·4 | 0·0 | 2·1** | 0·2 | 2·7** | 0·4 |
Mean value was significantly different from that of the 0 mg/d group: * P < 0·05, ** P < 0·0001.
ΔHbA1c represents the change in HbA1c levels before and after an 8-week intervention of Fx. P values for comparison of parameters among the three groups were calculated by one-way ANOVA, the Tukey–Kramer test for multiple comparisons and a non-parametric Steel–Dwass test.